Amidst uncertainty regarding the safety of some integrase inhibitors during pregnancy, a study shows that an older integrase inhibitor may be a good option for those with HIV who intend to give birth.
Best Practices for Most Vulnerable Populations: Transgender People, Adolescents, and the Recently Incarcerated
"As we think about the care cascade, we can't even test people [for HIV] to diagnose them if we can't get them in the door to a health care setting," one clinician said.
Gilead Sciences is working with the federal government to roll out its pre-exposure prophylaxis (PrEP) donation program. Here, we detail what we know so far about how this will be implemented.
If everyone living with HIV gets into care, do we have enough providers to support them? HIV doctors are proposing policy changes to address the workforce shortage.
Highlights of major findings on new antiretroviral therapies, including data on long-acting injectable solutions and new combination treatments packed into a single pill.
If an HIV-positive patient's viral load test results come back between 50 copies/mL and 200 copies/mL, consider retesting the same blood sample, Joseph Eron Jr., M.D., recommends. New study results suggest that the retest results may alter a clinicia...
High-dose, long-term omega-3 supplementation appears to yield improved triglycerides and C-reactive protein levels among HIV-positive people who have elevated triglycerides, but only after more than a year of use, a new study has found.
People with HIV face an increased pneumonia risk even after they've started HIV treatment. However, a recent study suggests that risk isn't affected by how suppressed the immune system was prior to starting treatment.